Abrar Ahmad Zargar

Mr. Abrar Ahmad Zargar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Ayush Journal of Integrative Oncology
Verified
Journal Article
Open access
VMVipasha Mehta
Vipasha Mehta
AZAbrar Ahmad Zargar
Abrar Ahmad Zargar
PAParas Attri
Paras Attri
SJSudhanshu Kumar Jha
Sudhanshu Kumar Jha
Cervical cancer remains a significant public health concern, ranking as the fourth most common cancer among women worldwide and a major contributor to cancer-related mortality, particularly in low- and middle-income countries. Despite advancements in screening programs that have reduced its incidence in industrialized nations, cervical cancer remains highly prevalent in developing regions due to inadequate human papillomavirus (HPV) screening and follow-up measures. In India, cervical cancer accounts for a substantial proportion of new cancer cases, emphasizing the urgent need for improved preventive strategies. HPV, the primary etiological agent, is the most common sexually transmitted infection, with various risk factors such as early sexual activity, multiple sexual partners, and immunosuppression playing a crucial role in its transmission. This review highlights the global burden of cervical cancer, the impact of HPV infection, and the challenges associated with prevention and early detection, underscoring the need for enhanced public health initiatives.

1 March 2023 in Global Health Journal
Verified
Journal Article
Open access
RGRuby Gangwar
Ruby Gangwar
AKArvind Kumar
Arvind Kumar
AZAbrar Ahmad Zargar
Abrar Ahmad Zargar
Amit SharmaAmit Sharma
Amit Sharma
RKRanjeet Kumar
Ranjeet Kumar

17 November 2022 in Health Sciences Review
Verified
Journal Article
Open access
IOIan Osoro
Ian Osoro
Amit SharmaAmit Sharma
Amit Sharma
MAMohammad Amir
Mohammad Amir
MVManisha Vohra
Manisha Vohra
RKRanjeet Kumar
Ranjeet Kumar
HBHemraj Bangar
Hemraj Bangar

12 April 2026 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
RGReena Gupta
Reena Gupta
PSPrem Saini
Prem Saini
VSVaibhav Srivastava
Vaibhav Srivastava
ITIttishree
Ittishree
MPManikandan P
Manikandan P
AZAbrar Ahmad Zargar
Abrar Ahmad Zargar

1 July 2026 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
AZAbrar Ahmad Zargar
Abrar Ahmad Zargar
RGReena Gupta
Reena Gupta
PKP Krishnamoorthy
P Krishnamoorthy
Chandipura virus (CHPV), a neurotropic, negative-sense RNA virus belonging to the genus Vesiculovirus (family Rhabdoviridae), has emerged as a significant cause of acute encephalitis syndrome (AES) in India, predominantly affecting children. Since the major outbreaks in 2003-2004 and the recent resurgence in 2024, CHPV has re-emerged as a high-fatality, climate-sensitive arboviral threat transmitted primarily by phlebotomine sandflies. The absence of specific antivirals or licensed vaccines underscores the need for comprehensive understanding and preparedness. This narrative review synthesizes available literature on CHPV epidemiology, outbreak history, molecular virology, transmission ecology, neuropathogenesis, host immune responses, diagnostic modalities, therapeutic candidates, and preventive strategies. Data from published outbreak reports, genomic analyses, experimental studies, and public health updates were critically examined to provide an integrated One Health perspective. CHPV outbreaks have been characterized by rapid disease progression, high case-fatality rates (often 30%-70%), and marked pediatric predominance. Molecular studies reveal a conserved vesiculovirus genomic organization (3'-N-P-M-G-L-5'), with emerging phylogenomic evidence indicating geographic clustering but limited global genomic representation. Neurotropism is mediated by rapid viral replication in the central nervous system, triggering microglial activation, oxidative stress, cytokine dysregulation, complement interactions, and Fas-mediated neuronal apoptosis. Diagnosis relies primarily on RT-PCR during the early viremic phase and IgM ELISA in later stages, though rapid field-deployable diagnostics remain unavailable. Experimental antiviral strategies, including ribavirin, favipiravir, lycorine, RNA interference, and immunomodulatory approaches, demonstrate preclinical promise but lack human clinical validation. Vector control and environmental management remain the cornerstone of prevention. Chandipura virus represents a re-emerging neuroinvasive arbovirus with significant public health implications in India. Strengthening AES surveillance, integrating genomic monitoring, developing rapid diagnostics, advancing antiviral and vaccine research, and implementing climate-informed vector control strategies are critical priorities. A coordinated One Health framework is essential to mitigate future outbreaks and reduce pediatric mortality.

6 June 2024 in Drug Development Research
Verified
Journal Article
Closed access
AZAbrar Ahmad Zargar
Abrar Ahmad Zargar